Jeon Seong Gak, Song Eun Ji, Lee Dongje, Park Junyong, Nam Yunkwon, Kim Jin-Il, Moon Minho
1Department of Biochemistry, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.
2Center for Organic Devices and Advanced Materials, Kyungsung University, Busan 48434, Republic of Korea.
Aging Dis. 2019 Apr 1;10(2):307-328. doi: 10.14336/AD.2018.0328. eCollection 2019 Apr.
Alzheimer's disease (AD), which is the most major cause of dementia, is a progressive neurodegenerative disease that affects cognitive functions. Even though the prevalence of AD is continuously increasing, few drugs including cholinesterase inhibitors and N-methyl D-aspartate-receptor antagonists were approved to treat AD. Because the clinical trials of AD drugs with single targets, such as β-amyloid and tau, have failed, the development of multi-target drugs that ameliorate many of the symptoms of AD is needed. Thus, recent studies have investigated the effects and underlying mechanisms of herbal formulae consisting of various herb combinations used to treat AD. This review discusses the results of clinical and nonclinical studies of the therapeutic efficacy in AD and underlying mechanisms of the herbal formulae of traditional Oriental medicines and bioactive compounds of medicinal plants.
阿尔茨海默病(AD)是痴呆症的最主要病因,是一种影响认知功能的进行性神经退行性疾病。尽管AD的患病率在持续上升,但包括胆碱酯酶抑制剂和N-甲基-D-天冬氨酸受体拮抗剂在内,仅有少数药物被批准用于治疗AD。由于针对单一靶点(如β-淀粉样蛋白和tau蛋白)的AD药物临床试验均告失败,因此需要开发能够改善AD多种症状的多靶点药物。因此,最近的研究探讨了用于治疗AD的各种草药组合所构成的中药复方的作用及其潜在机制。本综述讨论了传统东方药物的中药复方和药用植物生物活性化合物在AD治疗效果方面的临床和非临床研究结果及其潜在机制。